Optical Genome Mapping (OGM) Market - By Products & Services (Instrument, Services & Software), Application (Research, Diagnostics), Solution (Structural Variant Detection, Genome Assembly), End-user (Academic & Research Institute,), Global Forecast, 2024
Description
Optical Genome Mapping (OGM) Market - By Products & Services (Instrument, Services & Software), Application (Research, Diagnostics), Solution (Structural Variant Detection, Genome Assembly), End-user (Academic & Research Institute,), Global Forecast, 2024-2032
Global Optical Genome Mapping (OGM) Market will register a 24.1% CAGR from 2023 to 2032, attributed to continuous technological advancements in genomics research. The expanding array of digital platforms for genomic analysis will drive market size, offering researchers enhanced tools for comprehensive genome mapping. With breakthroughs in DNA sequencing technologies and the increasing integration of OGM in various applications, including personalized medicine, the market will witness substantial expansion as it meets the evolving demands of genomics research and diagnostic capabilities.
For instance, in 2023, Bionano Genomics, Inc. unveiled the Stratys™ system, designed for high-throughput optical genome mapping (OGM), along with VIA™ software. This integrated software platform facilitates the visualization, interpretation, and reporting of genome analysis for microarrays, OGM, and next-generation sequencing (NGS) data. The launch promises to bolster the optical genome mapping (OGM) industry by offering an integrated solution for high-throughput genome analysis and comprehensive data interpretation on a single platform.
The optical genome mapping (OGM) industry is segmented based on end-use, solution, and region.
The pharmaceutical and biotechnology companies segment will gain a noteworthy market share between 2023 and 2032, driven by the increasing integration of OGM technologies in drug discovery, genomics research, and personalized medicine initiatives. As pharmaceutical and biotechnology firms leverage OGM for precise genomic analysis, the demand for advanced solutions in this segment will surge. The robust applications of OGM in enhancing drug development processes will position it as a vital driver in this market.
The genome assembly segment will secure a notable optical genome mapping (OGM) market share by 2032, propelled by the increasing adoption of OGM technologies for comprehensive genome analysis and assembly. As researchers and healthcare professionals prioritize accurate and high-resolution genomic data, the genome assembly segment will experience substantial growth. With its crucial role in advancing genomics research and personalized medicine, this segment will stand as a key driver in shaping the trajectory of the optical genome mapping market.
Asia-Pacific optical genome mapping (OGM) industry share will grow at a significant CAGR from 2023 to 2032 due to the region's increasing focus on genomics research, advancements in healthcare infrastructure, and rising investments in biotechnology. As countries in the APAC region prioritize precision medicine and personalized genomics, the demand for OGM technologies will surge. The region's commitment to genomic advancements will position it as a pivotal contributor to the growth and development of the optical genome mapping market.
Table of Contents
160 Pages
- Chapter 1 Methodology & Scope
- 1.1 Market definition
- 1.2 Base estimates & calculations
- 1.3 Forecast calculation
- 1.4 Data validation
- 1.5 Data sources
- 1.5.1 Primary
- 1.5.2 Secondary
- 1.5.2.1 Paid sources
- 1.5.2.2 Public sources
- Chapter 2 Executive Summary
- 2.1 Optical genome mapping industry 360 degree synopsis, 2018 – 2032 (USD Million)
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Products & services trends
- 2.1.4 Application trends
- 2.1.5 Solution trends
- 2.1.6 End-user trends
- Chapter 3 Optical Genome Mapping Insights
- 3.1 Industry landscape, 2018 – 2032 (USD Million)
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Advancements in genomic research
- 3.2.1.2 Increasing demand for precision medicine
- 3.2.1.3 Rising government initiatives and funding
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 High cost of instruments and services
- 3.2.2.2 Lack of skilled technicians
- 3.3 Growth potential analysis
- 3.3.1 By products & services
- 3.3.2 By application
- 3.3.3 By solution
- 3.3.4 By end-user
- 3.4 Regulatory landscape
- 3.5 Porter’s analysis
- 3.6 PESTEL analysis
- Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis, 2023
- 4.3 Competitive analysis of major market players, 2023
- 4.4 Competitive positioning matrix, 2023
- 4.5 Strategic dashboard, 2023
- Chapter 5 Optical Genome Mapping Market Estimates and Forecast, By Products & Services, 2018-2032 (USD Million)
- 5.1 Key trends, by products & services
- 5.2 Instruments
- 5.3 Consumables & reagents
- 5.4 Services & software
- Chapter 6 Optical Genome Mapping Market Estimates and Forecast, By Application, 2018-2032 (USD Million)
- 6.1 Key trends, by application
- 6.2 Research
- 6.3 Diagnostics
- Chapter 7 Optical Genome Mapping Market Estimates and Forecast, By Solution, 2018-2032 (USD Million)
- 7.1 Key trends, by solution
- 7.2 Structural variant detection
- 7.3 Genome assembly
- 7.4 Microbial strain typing
- 7.5 Other solutions
- Chapter 8 Optical Genome Mapping Market Estimates and Forecast, By End-user, 2018-2032 (USD Million)
- 8.1 Key trends, by end-user
- 8.2 Pharmaceutical & biotechnology companies
- 8.3 Research & academic institutes
- 8.4 Diagnostic laboratories
- 8.5 Other end-users
- Chapter 9 Optical Genome Mapping Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)
- 9.1 Key trends, by region
- 9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 Rest of Asia Pacific
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
- 9.6 Middle East & Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 Rest of Middle East & Africa
- Chapter 10 Company Profiles
- 10.1 Bionano Genomics, Inc.
- 10.2 Nucleome Informatics Private Limited
- 10.3 Nabsys, Inc.
- 10.4 Praxis Genomics LLC
- 10.5 PerkinElmer, Inc.
- 10.6 OpGen, Inc.
- 10.7 SourceBio International Limited
- 10.8 MedGenome Labs Private Limited
- 10.9 Genohub Inc.
- 10.10 Cerba HealthCare
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
